Evaluation of focal low dose rate brachytherapy in men with low-intermediate risk prostate cancer

Definitive treatment for localized prostate cancer is associated with significant morbidity. Focal therapy for patients with low-intermediate risk features is an emerging modality aimed at reducing treatment-related toxicity. This thesis evaluates the dosimetry, toxicity and oncological outcomes of men receiving lesion-targeted focal low-dose-rate (LDR) brachytherapy for low to intermediate risk prostate cancer (PCa)